Related references
Note: Only part of the references are listed.Targeting histone deacetylases for combination therapies in neuroendocrine tumors
Teresa Gagliano et al.
CANCER GENE THERAPY (2021)
Identification of a subset of immunosuppressive P2RX1-negative neutrophils in pancreatic cancer liver metastasis
Xu Wang et al.
NATURE COMMUNICATIONS (2021)
The Bromodomain Inhibitor, INCB057643, Targets Both Cancer Cells and the Tumor Microenvironment in Two Preclinical Models of Pancreatic Cancer
Ana S. Leal et al.
CANCERS (2021)
Epigenetic and Transcriptional Control of the Epidermal Growth Factor Receptor Regulates the Tumor Immune Microenvironment in Pancreatic Cancer
Jinyang Li et al.
CANCER DISCOVERY (2021)
Epigenetic therapy inhibits metastases by disrupting premetastatic niches
Zhihao Lu et al.
NATURE (2020)
PIK3Cδ expression by fibroblasts promotes triple-negative breast cancer progression
Teresa Gagliano et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Epigenetic regulation of osteopontin splicing isoform c defines its role as a microenvironmental factor to promote the survival of colon cancer cells from 5-FU treatment
Siyuan Chang et al.
CANCER CELL INTERNATIONAL (2020)
Targeting KRAS(G12C): From Inhibitory Mechanism to Modulation of Antitumor Effects in Patients
Dongsung Kim et al.
CELL (2020)
FAK activity in cancer-associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreatic cancer
Sonia Zaghdoudi et al.
EMBO MOLECULAR MEDICINE (2020)
Cancer SLC43A2 alters T cell methionine metabolism and histone methylation
Yingjie Bian et al.
NATURE (2020)
Micro-environmental sensing by bone marrow stroma identifies IL-6 and TGFβ1 as regulators of hematopoietic ageing
Simona Valletta et al.
NATURE COMMUNICATIONS (2020)
Angiotensin Inhibition, TGF-beta and EMT in Cancer
Fabian Bernhard Pallasch et al.
CANCERS (2020)
Transcriptomic Analyses of Myeloid-Derived Suppressor Cell Subsets in the Circulation of Colorectal Cancer Patients
Varun Sasidharan Nair et al.
FRONTIERS IN ONCOLOGY (2020)
Epigenomic Reprogramming toward Mesenchymal-Epithelial Transition in Ovarian-Cancer-Associated Mesenchymal Stem Cells Drives Metastasis
Huihui Fan et al.
CELL REPORTS (2020)
The Intimate Relationship among EMT, MET and TME: A T(ransdifferentiation) E(nhancing) M(ix) to Be Exploited for Therapeutic Purposes
Ralf Hass et al.
CANCERS (2020)
α-Ketoglutarate attenuates Wnt signaling and drives differentiation in colorectal cancer
Thai Q. Tran et al.
NATURE CANCER (2020)
The structure-function relationship of oncogenic LMTK3
Angeliki Ditsiou et al.
SCIENCE ADVANCES (2020)
Tumor-Derived Myeloid Cell Chemoattractants and T Cell Exclusion in Pancreatic Cancer
Robert H. Vonderheide et al.
FRONTIERS IN IMMUNOLOGY (2020)
Interactive analysis of single-cell epigenomic landscapes with ChromSCape
Pacome Prompsy et al.
NATURE COMMUNICATIONS (2020)
How the ageing microenvironment influences tumour progression
Mitchell Fane et al.
NATURE REVIEWS CANCER (2020)
Tumour-reprogrammed stromal BCAT1 fuels branched-chain ketoacid dependency in stromal-rich PDAC tumours
Ziwen Zhu et al.
NATURE METABOLISM (2020)
Chemotherapy-generated cell debris stimulates colon carcinoma tumor growth via osteopontin
Jaimie Chang et al.
FASEB JOURNAL (2019)
Activation of AZIN1 RNA editing is a novel mechanism that promotes invasive potential of cancer-associated fibroblasts in colorectal cancer
Sho Takeda et al.
CANCER LETTERS (2019)
Integrin 11 in pancreatic stellate cells regulates tumor stroma interaction in pancreatic cancer
Jonas Schnittert et al.
FASEB JOURNAL (2019)
HDAC7-mediated control of tumour microenvironment maintains proliferative and stemness competence of human mammary epithelial cells
Valentina Cutano et al.
MOLECULAR ONCOLOGY (2019)
Genomic characterization of metastatic breast cancers
Francois Bertucci et al.
NATURE (2019)
HDAC7 regulates histone 3 lysine 27 acetylation and transcriptional activity at super-enhancer-associated genes in breast cancer stem cells
Corrado Caslini et al.
ONCOGENE (2019)
Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis
Divya Thomas et al.
MOLECULAR CANCER (2019)
Turning foes to friends: targeting cancer-associated fibroblasts
Xueman Chen et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Epigenetic therapy in immune-oncology
Peter A. Jones et al.
NATURE REVIEWS CANCER (2019)
Development and Preliminary Clinical Application of Circulating Tumor Cell Detection System for Prostate Cancer
Chengsong Cao et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2019)
HOTAIR: An Oncogenic Long Non-Coding RNA in Human Cancer
Qing Tang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Patterns of palliative care referral in ovarian cancer: A single institution 5 year retrospective analysis
Roni Nitecki et al.
GYNECOLOGIC ONCOLOGY (2018)
Paracrine and epigenetic control of CAF-induced metastasis: the role of HOTAIR stimulated by TGF-beta 1 secretion
Yu Ren et al.
MOLECULAR CANCER (2018)
Contemporary Management of Localized Resectable Pancreatic Cancer
Anuhya Kommalapati et al.
CANCERS (2018)
Differential Regulation of Methylation-Regulating Enzymes by Senescent Stromal Cells Drives Colorectal Cancer Cell Response to DNA-Demethylating Epi-Drugs
Khushboo Agrawal et al.
STEM CELLS INTERNATIONAL (2018)
Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway in pancreatic cancer
Lusheng Wei et al.
CELL DEATH & DISEASE (2018)
Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing
Michael Bartoschek et al.
NATURE COMMUNICATIONS (2018)
Human osteopontin: Potential clinical applications in cancer
Chengcheng Hao et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2017)
Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer
Ines Marmol et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Epigenetics in cancer stem cells
Tan Boon Toh et al.
MOLECULAR CANCER (2017)
Chromatin states define tumour-specific T cell dysfunction and reprogramming
Mary Philip et al.
NATURE (2017)
A loop of cancer-stroma-cancer interaction promotes peritoneal metastasis of ovarian cancer via TNFα-TGFα-EGFR
T-S Lau et al.
ONCOGENE (2017)
Malignant extracellular vesicles carrying MMP1 mRNA facilitate peritoneal dissemination in ovarian cancer
Akira Yokoi et al.
NATURE COMMUNICATIONS (2017)
Myeloid-Derived Suppressor Cells
Dmitry I. Gabrilovich
CANCER IMMUNOLOGY RESEARCH (2017)
The influence of the pre-metastatic niche on breast cancer metastasis
Josie Ursini-Siegel et al.
CANCER LETTERS (2016)
Genetics and biology of pancreatic ductal adenocarcinoma
Haoqiang Ying et al.
GENES & DEVELOPMENT (2016)
The epigenetic landscape of T cell exhaustion
Debattama R. Sen et al.
SCIENCE (2016)
Histone Modifications and Cancer
James E. Audia et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
Human carcinoma-associated mesenchymal stem cells promote ovarian cancer chemotherapy resistance via a BMP4/HH signaling loop
Lan G. Coffman et al.
ONCOTARGET (2016)
The biology and function of fibroblasts in cancer
Raghu Kalluri
NATURE REVIEWS CANCER (2016)
The MEF2-HDAC axis controls proliferation of mammary epithelial cells and acini formation in vitro
Andrea Clocchiatti et al.
JOURNAL OF CELL SCIENCE (2015)
Pancreatic cancer: from state-of-the-art treatments to promising novel therapies
Ignacio Garrido-Laguna et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
POSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer
Beth Y. Karlan et al.
GYNECOLOGIC ONCOLOGY (2014)
Specific Mesothelial Signature Marks the Heterogeneity of Mesenchymal Stem Cells From High-Grade Serous Ovarian Cancer
Roberto Verardo et al.
STEM CELLS (2014)
Epigenetic mechanisms of breast cancer: an update of the current knowledge
Seher Karsli-Ceppioglu et al.
EPIGENOMICS (2014)
Class IIa HDACs repressive activities on MEF2-depedent transcription are associated with poor prognosis of ER+ breast tumors
Andrea Clocchiatti et al.
FASEB JOURNAL (2013)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Human ovarian carcinoma-associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production
Karen McLean et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Ovarian Cancer Development and Metastasis
Ernst Langyel
AMERICAN JOURNAL OF PATHOLOGY (2010)
Overexpression and involvement of special AT-rich sequence binding protein 1 in multidrug resistance in human breast carcinoma cells
Qing-Quan Li et al.
CANCER SCIENCE (2010)
Wnt activity defines colon cancer stem cells and is regulated by the microenvironment
Louis Vermeulen et al.
NATURE CELL BIOLOGY (2010)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome
Richard W. Tothill et al.
CLINICAL CANCER RESEARCH (2008)
Descriptive analysis of estrogen receptor (ER)negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype - A population-based study from the California Cancer Registry
Katrina R. Bauer et al.
CANCER (2007)
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
M. Dominici et al.
CYTOTHERAPY (2006)